If you’re evaluating Top Polymorph CDMOs, you’re not buying “XRPD capability.” You’re choosing a partner who can take a solid-state risk hiding inside a tidy chemical name and turn it into something controlled, defensible, and inspection-ready—through scale-up, shipping, storage, and change control. Polymorphs don’t fail loudly. They fail as drift: dissolution swings, stability surprises, filtration […]
Tag: MycoVista Biotech
The Future of Biomanufacturing is Integration
In 2025, the biotechnology industry stands at one of the most consequential inflection points in its history. For the past decade, modalities such as mRNA therapeutics, engineered cell therapies, and CRISPR-based gene editing have transitioned from bold scientific experiments to clinical realities with real patients, real outcomes, and billion-dollar markets. The pipeline is richer than […]
10 Reasons Why MycoVista is the Best CDMO Partner in California
MycoVista is your California CDMO—born in the world’s most vibrant biotech corridor and specialized in strain development, protein refolding, and biosimilars. We bring West Coast speed with enterprise-grade discipline: phase-appropriate GMP that keeps every program aligned with regulatory expectations, quality assurance, and commercial readiness from day one. What truly sets MycoVista apart, though, is the […]